Navigation Links
Avantium Appoints Jonathan Wolfson to its Supervisory Board
Date:1/31/2013

AMSTERDAM, January 31, 2013 /PRNewswire/ --

Avantium announced the appointment of Jonathan Wolfson to its Supervisory Board. Jonathan Wolfson is Chief Executive Officer and co-founder of Solazyme. Solazyme is a leading industrial biotechnology company producing renewable oil and bioproducts from microalgae for fuels, chemicals, nutrition and personal care products. Solazyme (SZYM) is a US stock listed company at NASDAQ. Mr. Wolfson and Solazyme have received numerous awards for their technology pioneering role in the industrial biotechnology industry. Mr. Wolfson holds J.D. and M.B.A. degrees from the NYU School of Law and the NYU Stern School of Business

Jonathan Wolfson said on his appointment:"I am very happy to join the Supervisory Board at Avantium.  I have known the Company for years and have been increasingly impressed with its world class catalytic technology and the incredibly exciting development of the YXY technology platform.  I look forward to working with the company as it brings its disruptive biobased plastics and chemicals to market."

"We are proud to have Jonathan Wolfson appointed to our Supervisory Board", says Tom van Aken , CEO of Avantium. "Jonathan has played a major role in the successful development of Solazyme, its successful IPO and the formation of strategic partnerships in the food, cosmetics and fuels industries. His experience and insights in bringing biobased chemicals to the market, will be very valuable for Avantium to commercialize its YXY technology for the production and use of FDCA and PEF."

About Avantium

Avantium is a game-changing renewable chemicals company with leadership in advanced catalysis R&D. It developed the breakthrough YXY technology, a proprietary process to convert carbohydrates into the green building blocks FDCA for making biobased plastics and biobased chemicals at cost competitive prices in large markets. Avantium's lead application PEF (polyethylene furanoate) fulfils key criteria to become the next generation biobased plastics for bottles, film and fibers. Avantium has demonstrated the value and commercial potential of its unique technology by collaborating with leading companies like The Coca-Cola Company and Danone for the development of 100% biobased PEF bottles. Avantium plans to have the first commercial scale manufacturing plant operational by 2016. Avantium laboratories and headquarters are based in Amsterdam, the Netherlands.


'/>"/>
SOURCE Avantium
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Arecor Appoints Dr. Sarah Howell as Chief Operating Officer
2. Elsevier / MEDai Appoints Tom Zajac as New President
3. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
4. Hybrid Fuels, Inc. Appoints Industry Expert as New CEO
5. BioStorage Technologies Appoints New Member to Board of Directors
6. Selexis SA Appoints Yemi Onakunle as Vice President of Strategic and Market Development
7. Oxford BioTherapeutics Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director
8. PuraMed BioScience, Inc. Appoints Sue A. Baacke, CPA, as CFO
9. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
10. MAP Pharmaceuticals Appoints W. James OShea to Board of Directors
11. Veracyte Appoints Mark Spring as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... At its ... announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief research scientist of ... been selected for membership in ARCS Alumni Hall of Fame . ASTER ...
(Date:10/11/2017)... ... ... eye wash is a basic first aid supply for any work environment, but most personal ... rinse first if a dangerous substance enters both eyes? It’s one less decision, and likely ... dual eye piece. , “Whether its dirt and debris, or an acid or alkali, getting ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... pathology, announced today it will be hosting a Webinar titled, “Pathology is going ... Pathology Associates , on digital pathology adoption best practices and how Proscia improves ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , ... of Cancer Research, London (ICR) and ... with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple ... as MUK nine . The University of ... is partly funded by Myeloma UK, and ICR will perform ...
Breaking Biology Technology:
(Date:4/5/2017)... -- KEY FINDINGS The global market for ... of 25.76% during the forecast period of 2017-2025. The ... the growth of the stem cell market. ... INSIGHTS The global stem cell market is segmented on ... stem cell market of the product is segmented into ...
(Date:3/30/2017)... -- Trends, opportunities and forecast in this market to ... AFIS, iris recognition, facial recognition, hand geometry, vein recognition, ... industry (government and law enforcement, commercial and retail, health ... and by region ( North America , ... , and the Rest of the World) ...
(Date:3/24/2017)... Research and Markets has announced the addition ... Trends - Industry Forecast to 2025" report to their offering. ... The Global Biometric ... of around 15.1% over the next decade to reach approximately $1,580 ... market estimates and forecasts for all the given segments on global ...
Breaking Biology News(10 mins):